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ABSTRACT 21 
Some bacteria, when infected by their viral parasites (bacteriophages), undergo a suicidal 22 
response that also terminates productive viral replication (abortive infection; Abi). This response 23 
can be viewed as an altruistic act protecting the uninfected bacterial clonal population. Abortive 24 
infection can occur through the action of Type III protein-RNA toxin-antitoxin (TA) systems, 25 
such as ToxINPa from the phytopathogen, Pectobacterium atrosepticum. Rare spontaneous 26 
mutants evolved in the generalized transducing phage, ΦM1, which escaped ToxINPa-mediated 27 
abortive infection in P. atrosepticum. ΦM1 is a member of the Podoviridae and member of the 28 
“KMV-like viruses”, a subset of the T7 supergroup. Genomic sequencing of ΦM1 escape 29 
mutants revealed single-base changes which clustered in a single open reading frame. The 30 
“escape” gene product, M1-23, was highly toxic to the host bacterium when over-expressed, but 31 
mutations in M1-23 that enabled an escape phenotype caused M1-23 to be less toxic. M1-23 is 32 
encoded within the DNA metabolism modular section of the phage genome, and when it was 33 
over-expressed, it co-purified with the host nucleotide excision repair protein, UvrA. While the 34 
M1-23 protein interacted with UvrA in co-immunoprecipitation assays, a UvrA mutant strain 35 
still aborted ΦM1, suggesting that the interaction is not critical for the Type III TA Abi activity. 36 
Additionally, ΦM1 escaped a heterologous Type III TA system (TenpINPl) from Photorhabdus 37 
luminescens (reconstituted in P. atrosepticum) through mutations in the same protein, M1-23. 38 
The mechanistic action of M1-23 is currently unknown but further analysis of this protein could 39 
provide insights into the mode of activation of both systems.  40 
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IMPORTANCE 41 
Bacteriophages, the viral predators of bacteria, are the most abundant biological entities and are 42 
important factors in driving bacterial evolution. In order to survive infection by these viruses, 43 
bacteria have evolved numerous anti-phage mechanisms. Many of the studies involved in 44 
understanding these interactions have led to the discovery of biotechnological and gene-editing 45 
tools, most notably restriction enzymes and more recently the CRISPR-Cas systems. Abortive 46 
infection is another such anti-phage mechanism that warrants further investigation. It is unique in 47 
that activation of the system leads to the premature death of the infected cells. As bacteria 48 
infected with the virus are destined to die, undergoing precocious suicide prevents the release of 49 
progeny phage and protects the rest of the bacterial population. This altruistic suicide can be 50 
caused by Type III toxin-antitoxin systems and understanding the activation mechanisms 51 
involved will provide deeper insight into the abortive infection process.  52 
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INTRODUCTION 53 
It is estimated that there are more than 1030 bacteriophages (phages) on Earth, outnumbering 54 
their bacterial hosts tenfold (1, 2). These large viral numbers generate an estimated 1025 55 
infections per second, imposing a large evolutionary selection pressure on bacteria (2). In 56 
response, bacteria have evolved a plethora of defensive mechanisms to counter these 57 
overwhelming phage insults (3). Consequently, phages are continually evolving counter defences 58 
and thus both the host and parasite are locked together in a perpetual molecular arms race (4). 59 
Bacterial anti-phage mechanisms that have been observed include adsorption prevention, 60 
restriction-modification systems, superinfection systems, abortive infection (Abi) systems and 61 
the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems (3). Studies 62 
of these phage-host interactions have been translated into significant molecular technologies and 63 
reagents, most notably the use of restriction enzymes in cloning (5) and, more recently the 64 
CRISPR-Cas systems use of which is currently revolutionising eukaryotic molecular biology (6).  65 
One of the more curious anti-phage mechanisms is Abi where, post-infection, the host 66 
bacterium is driven towards precocious cell death. This simultaneously terminates viral 67 
replication and prevents a productive phage burst. Thus, the Abi response in infected cells 68 
protects the bacterial population from progeny phage infection in a process akin to an altruistic 69 
suicide (3). The majority of Abi systems have been studied in Lactococcus lactis (7), an 70 
important bacterium in the dairy industry (8). Phage contamination in fermentation cultures can 71 
cause substantial economic losses. Consequently, considerable research has been conducted to 72 
identify and define many anti-phage systems useful for control of bacteriophages in lactococcal 73 
fermentations (7). However, there are also well-studied Abi systems in other bacteria such as 74 
Escherichia coli, namely the Rex, Lit and PrrC systems (9-11). A commonly recurring theme of 75 
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Abi systems is that they involve the activation of a toxic protein that is suppressed under normal 76 
growth conditions. However, environmental insults, phages, or other physiological stresses can 77 
activate the toxin. Once activated, the toxin interferes with an essential cellular process and 78 
induces bacteriostasis, ultimately leading to cell death. This is a common feature shared by toxin-79 
antitoxin systems (12).  80 
Toxin-antitoxin (TA) systems were originally discovered on plasmids where they 81 
function as plasmid maintenance systems through post-segregational killing mechanisms (13). 82 
They have been found in the majority of bacteria, both on plasmids (13) and chromosomally 83 
(14), as well as in archaea (15) and phages (16). TA systems are typically bicistronic, comprising 84 
a bacteriostatic or bactericidal toxic protein that is neutralized either directly or indirectly by an 85 
antitoxin counterpart. To date there are six TA system Types which are characterized by the 86 
nature and mode of action of their antitoxins (17). In the case of Type III TA systems, an RNA 87 
antitoxin directly interacts with the toxic protein to form a non-toxic complex (18). 88 
At least four Types of TA systems confer phage resistance. These are the hok/sok systems 89 
of Type I (19), mazEF, rnlAB and lsoAB of Type II (20, 21), ToxINPa, TenpINPl and AbiQ of 90 
Type III (22-24), AbiE of Type IV (25) and sanaTA (which is currently not characterized but 91 
likely to be a Type II, having a proteinaceous antitoxin) (26). ToxINPa was the first Type III 92 
system to be identified and originated from Pectobacterium atrosepticum plasmid pECA1039. 93 
The toxin ToxNPa is encoded by toxN and the antitoxin ToxIPa is encoded by toxI, a 36 nucleotide 94 
sequence repeated five and a half times (22). The ToxINPa system provides protection against 95 
multiple phages infecting not only its cognate host, P. atrosepticum, but also other enteric 96 
bacteria including E. coli DH5α and Serratia marcescens Db11 (22). One such aborted 97 
pectobacterial phage is the Myoviridae phage, ΦTE. ΦTE phages that were no longer sensitive to 98 
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ToxINPa had evolved to encode an RNA antitoxic mimic of ToxIPa, which was able to neutralize 99 
ToxNPa (27). However, it did not shed light on how ToxINPa was activated during phage 100 
infection. In fact, very little is known about the activation of any Type III toxin-antitoxin 101 
systems. The other Type III system that has been studied for Abi is AbiQ from Lactococcus 102 
lactis, which shows structural homology with ToxNPa (24). Three lactococcal siphophages that 103 
were aborted by AbiQ have been examined in detail. However, all had mutations in genes of 104 
unknown functions; orf38, m1 and e19 of phages P008, bIL170 and c2, respectively (28). The 105 
AbiQ system was also reconstructed in a heterologous host, E. coli MG1655, and was shown to 106 
confer resistance to a range of coliphages including T4 and T5. However, escape mutants could 107 
only be obtained for a single phage (Phage 2). Escapes of this phage showed mutations in orf210, 108 
a predicted DNA polymerase (28). Studies of the AbiQ system suggests there may be multiple 109 
potential routes of escape involving several genes from different phages in the activation of a 110 
single Abi system. 111 
Previously it was shown that the pectobacterial phage, ΦM1, was aborted by the ToxINPa 112 
system and was able to escape by evolving rare mutants (29). ΦM1 was isolated in 1995 during a 113 
search for new transducing phages effective as genetic tools in P. atrosepticum (30). Here we 114 
characterize ΦM1 and its escape mutants in depth. All ΦM1 escape phages evolved through 115 
mutations in a gene encoding a small highly toxic protein, M1-23. When the related TenpINPl 116 
system of Photorhabdus luminescens was transferred to P. atrosepticum, the system was able to 117 
abort ΦM1 in the heterologous host. Furthermore, it was possible to select spontaneous viral 118 
mutants that escaped both ToxINPa and TenpINPl through mutations in M1-23. 119 
 120 
 121 
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MATERIALS AND METHODS 122 
Bacterial strains, bacteriophages and growth conditions 123 
Bacterial strains and bacteriophages are listed in Table 1. E. coli strains were grown at 37°C and 124 
Pectobacterium atrosepticum SCRI1043 (Pba) (31) was grown either at 25°C on agar plates or at 125 
25, 28, or 30°C as required for liquid culture, in Luria broth (LB) at 250 rpm or on LB-agar 126 
(LBA). LBA contained 1.5% w v-1 or 0.35% w v-1 agar, to make LBA plates or top-LBA, 127 
respectively. Bacterial growth was measured using a spectrophotometer set to 600 nm. When 128 
required, media were supplemented with ampicillin (Ap) at 100 µg ml-1, chloramphenicol (Cm) 129 
at 50 µg ml-1, kanamycin (Km) at 50 µg ml-1 tetracycline (Tc) at 10 µg ml-1, Isopropyl β-D-130 
thiogalactopyranoside (IPTG) at 0.5 mM or 2, 6-diaminopimelic acid (DAPA) at 300 µM. 131 
Phage spontaneous escape mutants were isolated as described previously (27). Phage lysates 132 
were made as described (32). Phages were stored at 4°C in phage buffer; 10 mM Tris-HCl pH 133 
7.4, 10 mM MgSO4, 0.01% w v-1 gelatin. A few drops of chloroform saturated with sodium 134 
bicarbonate was also added to the phage lysates to maintain sterility. Efficiency of Plating (EOP) 135 
was calculated after overnight incubation of serial dilutions of phage lysates in a top-LBA lawn 136 
of each bacterial host, and recorded as plaque forming units (pfu) on test strain/pfu on control 137 
strain. EOPs were calculated using Pba wild type (wt) or a frame-shifted toxN plasmid strain as 138 
the negative control (22). 139 
 140 
ΦM1 genomic sequencing 141 
Bacteriophage DNA was extracted with phenol/chloroform, using phase-lock gel tubes 142 
(Eppendorf) and following the manufacturer’s instructions, as for bacteriophage λ. The extracted 143 
DNA was subjected to pyrosequencing on a Roche 454 Genome Sequencer FLX at the DNA 144 
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sequencing facility, Department of Biochemistry, University of Cambridge. Contiguous read 145 
segments (contigs) were assembled using Newbler (Roche). The ΦM1 wild type sequence was 146 
determined in one lane of the sequencing run. The three escape phage genomes were individually 147 
tagged with independent identifying sequences, then combined and sequenced as a mixture 148 
within a second lane. For each of the four phages, the final assembled sequence consisted of a 149 
single contig of approximately 43,500 base-pairs (bp). The average read length was 250 bp. The 150 
wild type sequence was assembled from 13,628 reads, leading to approximately 78x coverage of 151 
the full sequence. Escape phage ΦM1-A, -B and -D sequences were assembled from 4925, 5188 152 
and 5886 reads, respectively, resulting in approximately 29x coverage of each sequence.  153 
When viewing the sequence data, beginning at 43,572 bp (in the final ΦM1 wt sequence), 154 
there were fifteen tandem repeats of the 2 bp sequence ‘TG’. The number of TG repeats varied 155 
between the raw sequences of each phage, from seventeen in ΦM1-A to one in ΦM1-B and 156 
seven in ΦM1-D. The exact number of TG repeats in each phage genome could not be accurately 157 
confirmed by sequencing a specific amplicon. Therefore, in order to sequence this region, it was 158 
specifically amplified (Primers TRB107/108 and TRB115/116) and cloned into pBR322 (NEB). 159 
From the resulting plasmid DNA, the region was successfully sequenced on both forward and 160 
reverse strands. 161 
Potential ORFs were identified using gene prediction tools such as ORFfinder 162 
(http://www.ncbi.nlm.nih.gov/projects/gorf/), GeneMark.hmm (33) and Glimmer (34), along 163 
with BLAST (35) homology searches and manual annotation. RBSfinder (36) was used to 164 
predict ribosome-binding sites (Table S1). ΦM1 tRNAs were identified using tRNAScan-SE 165 
(37). The BDGP Neural Network Promoter Prediction (38) program did not identify any 166 
consensus promoters. The program, “Stretcher”, from the EMBOSS suite 167 
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(http://www.ebi.ac.uk/Tools/psa/emboss_stretcher/nucleotide.html), was used for global 168 
nucleotide alignments. The ΦM1 genome was viewed and annotated using Artemis (39). 169 
 170 
Plasmid construction 171 
Molecular biology techniques were performed as described previously (40). All primers were 172 
obtained from Sigma-Genosys and Invitrogen and are listed in Table 2. All plasmids constructed 173 
and/or used in this study are listed in Table 3, along with the primers used for their construction. 174 
All recombinant plasmid sequences were verified by DNA sequencing. 175 
 176 
Measuring ToxIPa and ToxNPa Levels during Phage Infection 177 
Two cultures of 180 ml LB containing Ap were inoculated with 2 ml overnight cultures of Pba 178 
(pBR322) or Pba (pMJ4), respectively. Cultures were grown at 25°C and shaken at 180 rpm to 179 
an OD600 of 1 and each split into 2× 80 ml; one of which was infected with phage at a 180 
multiplicity of infection (MOI) of 1, while the other served as a negative control without 181 
infection. Cultures were left for 10 min without shaking for phage adsorption, then shaken at 182 
25°C and 180 rpm. Samples for OD600 measurement, RNA preparation and protein analysis were 183 
taken regularly during infection. Total RNA was isolated using the TRIZOL method and 184 
subsequently DNase treated. Cell pellets for Western blot analysis were resuspended in 1× PBS 185 
according to OD600 measurement. 186 
 187 
Western blot analysis of ToxNPa during infection 188 
One ml samples of the cell cultures were taken, pelleted and resuspended in 1× PBS according to 189 
OD600. For samples taken during ΦM1 phage infection, the protein was quantified using a 190 
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Nanodrop (ThermoScientific) and equal amounts of protein (150 µg) were resolved by 12% 191 
PAGE. Proteins were transferred to a PVDF-membrane and blocked for 1 h in 1× PBS 192 
containing 5% milk powder. Immunodetection of FLAG-tagged ToxN was performed overnight 193 
at 4°C in 1× PBS using anti-FLAG M2 antibody (Sigma). Goat anti-mouse IgG-HRP (Santa 194 
Cruz) was used as secondary antibody. Bands were visualized on X-Ray film using the 195 
SuperSignal West Pico Chemiluminescent Substrate Kit (Pierce). SdhE-FLAG expressed from 196 
pMAT7 (41), was used as a control in the blot tracking ΦM1 infection. 197 
 198 
S1-nuclease Protection Assays 199 
An antisense probe covering the complete ToxIPa sequence was made by amplification of the 200 
ToxIPa locus from plasmid pTA110, using primers PF217 and PF218, and subsequent in vitro 201 
transcription and gel extraction of the probe as described (42), generating a uniformly 32P-UTP 202 
labeled antisense transcript. Ten µg of DNase-treated total RNA was hybridized to the antisense 203 
probe overnight at 68°C in a total volume of 30 µl containing 22% or 6% formamide for the 204 
ΦM1 and ΦM1-O total RNA, respectively, 40 mM PIPES/KOH (pH 6.4), 1 mM EDTA and 400 205 
mM NaCl. Reactions were treated with S1-nuclease (Invitrogen) (1 U µl-1) for 1.5 h at 37°C in a 206 
total volume of 300 µl 1× S1-nuclease buffer, to degrade any single-stranded nucleic acids. 207 
Double-stranded hybridization products were precipitated, resuspended and resolved by 10% 208 
PAGE. Bands were visualized by phosphorimaging (BioRad Personal FX phosphorimager).  209 
 210 
 211 
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Toxicity assays 212 
When required, media were supplemented with Ap, D-glucose (glu) at 0.2% w v-1 and L-213 
arabinose (L-ara) at 0.1% w v-1. Pba strains containing two plasmids were grown as 10 ml 214 
overnight cultures, then used to inoculate 25 ml LB, Ap, Cm and glu in 250 ml conical flasks, 215 
and grown at 25°C and 250 rpm, from a starting OD600 of ~0.04, until exponential phase (~1 x 216 
108 colony forming units (cfu) ml-1). Samples were removed, washed with phosphate buffered 217 
saline (PBS), serially diluted and plated for viable counts at 25°C on LBA, Ap, Cm plates 218 
containing either i) glu, to repress expression or; ii) L-ara, to induce expression. Single plasmid 219 
strains were treated in the same way, except omitting Cm from the growth conditions.  220 
 221 
β-galactosidase assays 222 
Liquid assays for LacZ activity were performed using the substrate 4'-Methylumbelliferyl-β-D-223 
glucuronide (MUG) as described before (43). Briefly, samples of culture (150 μl) were taken at 224 
each time point and frozen at –80°C until required. Ten μl aliquots of each sample culture were 225 
frozen at –80°C for 10 min and then thawed at room temperature. Next, 100-μl reaction buffer 226 
(PBS, 400 μg ml-1 lysozyme, 250 μg ml-1 MUG) was added and samples were immediately 227 
monitored in a Gemini XPS plate reader with the following parameters: excitation 360 nm, 228 
emission 450 nm, cut-off 435 nm, eight reads per well, and measured every 30 s for 30 min. RFU 229 
min−1 was calculated from a period of linear increase in fluorescence, normalized to the OD600 of 230 
the sample. 231 
 232 
 233 
 234 
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Pulldown of ToxINPa and M1-23 from cell lysates 235 
Using ΦM1 and ΦM1-O genomic DNA (gDNA), ΦM1-23 and M1-O-23 were amplified via 236 
PCR using TRB111 and TRB135 as primers. The products were then digested using the relevant 237 
restriction enzymes, ligated into pQE-80L and then used to transform ER2566. For the ToxINPa 238 
strains, pMJ4 (which contains ToxINPa-FLAG) was used and a new plasmid was constructed to 239 
make a ToxNPa-chitin binding domain (CBD) fusion. This was produced using pTA46 and 240 
primers TRB37 and TRB38. The plasmid pTRB14 was then used to transform ER2566 which 241 
had previously been transformed with pTRB18-KP14 that contains a ToxIPa sequence. 242 
Expression strains were grown in 2xYT media (per litre: 16 g tryptone, 10 g yeast extract, 243 
5 g NaCl) at 37°C until an OD600 of approximately 1. The cultures were then induced with the 244 
appropriate supplement (0.5 mM IPTG for M1-23-6His and M1-O-23-6His) and then left to 245 
grow overnight at 18°C. No inducers were added to the tagged ToxINPa containing strains as it is 246 
constitutively expressed on pBR322. 247 
Cells were harvested by centrifugation at 8,000 x g and the pellets were re-suspended in 248 
10 ml lysis buffer (50 mM NaH2PO4.2H20, 500 mM NaCl, 10 mM imidazole, 10% glycerol, pH 249 
8.0) per 500 ml of original culture volume. Cells were then lysed by four passes through a high-250 
pressure homogeniser (emulsiflex at up to 15,000 psi). Lysed cells were centrifuged at 8,000 x g 251 
and the supernatants kept for further co-immunoprecipitation experiments. 252 
In the experiments using M1-23-6His and M1-O-23-6His as bait, 1.5 ml Ni2+ resin 253 
columns were used with ToxINPa-FLAG. The columns were equilibrated using 3 column 254 
volumes (CV) of lysis buffer before loading of the His-tagged protein lysates onto the resin. 255 
Loaded resins were washed with 5 column volumes (CV) of wash buffer 1 (20 mM imidazole) 256 
followed by 10 CV of wash buffer 2 (40 mM imidazole). The FLAG-tagged ToxINPa was then 257 
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loaded onto the appropriate columns via continuous flow for at least 3 h (often overnight) before 258 
washing with 5 CV wash buffer 1 and 10 CV wash buffer 2. 259 
Samples were eluted from the resin using elution buffer (250 mM imidazole) via 3 x 1 ml 260 
fractions and analysed by western blot analysis using antibodies against His- (Novagen) and 261 
FLAG- (Sigma) tags. Briefly, samples were run on 12.5 % Tris-tricine gels and transferred onto 262 
Immobilon-P PVDF membranes (pore size: 0.45 µm; Millipore) at 250 mA for 90 min. 263 
Membranes were then blocked with a 5% milk + PBST solution for 1 h before incubation with 264 
anti-His and anti-FLAG antibodies at 1:10,000 for 2 h. After incubation, the membranes were 265 
washed 3x 5 min in PBST and then incubated with the secondary anti-mouse antibody (Sigma) at 266 
1:10,000 for 1 h before washing again 3x 5 min in PBST. The blots were then probed with 267 
Immobilon-Western chemiluminescent HRP-substrate (Millipore) and developed. 268 
For experiments where ToxINPa was used as the bait, the strain expressing ToxINPa-CBD 269 
was used with a 1 ml chitin resin. The protocol and buffers used were as described by the 270 
manufacturer (NEB). Briefly, the ToxINPa-CBD lysate was loaded onto the column and washed 271 
with 40 ml of column buffer. The M1-23 or control pQE-80L lysates were then added onto their 272 
respective columns. The columns were washed twice with 10 ml then 27 ml of column buffer 273 
followed by a DTT flush, 5-7 ml for 10 min. Columns were then left to incubate overnight at 274 
room temperature. After incubation, elution was carried out using 15 ml of column buffer. 275 
Western blots were then performed on the samples as previously described. 276 
 277 
Measuring ToxIPa levels after ToxINPa pulldowns with M1-23 278 
ToxIPa levels were measured in the eluted fractions of the ToxINPa-CBD, chitin resin column 279 
experiments. Samples from cultures expressing either M1-23 or containing the pQE-80L vector 280 
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control were separated by electrophoresis at 80 volts, using a 1% w v-1 agarose gel made with 281 
0.5x TAE. Additionally, samples were also measured by Nanodrop (Labtech, ND-1000). 282 
 283 
Co-immunoprecipitation of UvrA and M1-23 284 
UvrA-6His was constructed by amplification from the E. coli W3110 genome using primers 285 
TRB337 and TRB338. PCR products were then digested with the appropriate restriction 286 
enzymes and the digested product was purified, then ligated into pQE-80L to generate UvrA 287 
with an N-terminal His-tag, pTRB301. This plasmid was then used to transform the E. coli 288 
expression strain ER2566. Likewise, UvrA-FLAG was constructed in a similar way but using 289 
primers TRB330 and TRB332 and ligated into pBAD33. 290 
Expression and subsequent experiments were performed as described earlier using His-291 
tagged proteins as bait on Ni2+ resin. Expression of UvrA-FLAG was induced by addition of 292 
0.02% arabinose. 293 
 294 
Construction of the P. atrosepticum uvrA mutant 295 
The uvrA mutant of Pba was constructed via allelic exchange. This was performed using the 296 
plasmid pKNG-uvrA, which was derived from pKNG101. The plasmid was constructed by 297 
firstly amplifying 500 bp regions up- and downstream of the uvrA gene in P. atrosepticum 298 
SCRI1043. These two sequences were then ligated together with a kanamycin cassette inserted 299 
in-between. 300 
The suicide vector derivative, pKNG-uvrA, was used to transform E. coli β2163 and 301 
grown overnight in the appropriate selective media. This acted as the donor strain and, along 302 
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with an overnight of the recipient strain, P. atrosepticum SCRI1043, was pelleted and 303 
resuspended in LB. Both cultures were then mixed in the ratios of 2:1, 1:1 and 1:2 up to a final 304 
volume of 100 µl. The resulting mixtures were then spotted on to DAPA-containing plates and 305 
incubated at 25°C for 24 h. After mating, the patches were resuspended in 100 µl LB, serially 306 
diluted and spread onto LBA plates containing tetracyline. These plates were incubated for 2 d at 307 
25°C and colonies that appeared were picked and grown in LB overnight. The subsequent 308 
overnight cultures were serially-diluted and 50 µl samples plated onto LBA plates containing 309 
10% w v-1 sucrose. Colonies were also patched onto LBA plates containing kanamycin and the 310 
gene deletion was confirmed using colony PCR and DNA sequencing. The strain was confirmed 311 
phenotypically as UvrA-negative by demonstrating a hypersensitivity to UV light (Fig. S1).  312 
 313 
Genomic sequence accession number 314 
The genome of ΦM1 has been submitted to GenBank under the accession number JX290549. 315 
 316 
 317 
 318 
 319 
 320 
 321 
 322 
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RESULTS 323 
ΦM1 is a ‘KMV-like’ virus 324 
ΦM1 is a generalized transducing phage of Pectobacterium atrosepticum (Pba; previously 325 
Erwinia carotovora subsp. atroseptica) (30). This Podovirus is aborted by the Type III TA 326 
system, ToxIN from Pba, ToxINPa (22). ΦM1 generates spontaneous ‘escape’ mutants that are 327 
resistant to Abi by ToxINPa, at a rate of ~10-5 (29). In order to improve our understanding of 328 
ToxINPa-phage interactions we sequenced ΦM1 wt and three previously isolated escape phages, 329 
ΦM1-A, -B and -D (29).  330 
Using BLAST searches (35), ΦM1 was classified as a member of the “KMV-like” 331 
subgroup of the T7 supergroup of phages (44). T7-like phage linear genomes are typically 332 
flanked by direct terminal repeats (DTRs) (45). However, the DTRs could not be defined by a 333 
‘primer walking’ strategy along the ΦM1 genome, consistent with results from another “KMV-334 
like” phage, LIMEzero (46). The presence and approximate size of the DTRs, 293 bp, was 335 
therefore confirmed through restriction digest analysis of the ΦM1 genome (Fig. S2). The final 336 
ΦM1 wild type genome was 43,827 bp long with a GC content of 49.30%. In comparison, the 337 
host Pba genome has a GC content of 50.97% (31). The two genomes therefore closely match 338 
one another in GC content. 339 
 Global nucleotide alignments were performed to assess the relationship between the 340 
“KMV-like” phages and ΦM1. When compared with ΦM1, phage VP93 (43,931 bp) (47), phage 341 
LKA1 (41,593 bp) (44), phage LKD16 (43,200 bp) (44) and ΦKMV itself (42,519 bp) (45) 342 
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shared between 48.2% to 49.2% sequence identity. These values match well to those of other 343 
“KMV-like” phages (46). 344 
 ΦM1 encodes 52 putative genes, named phiM1-1 to phiM1-52. The gene products were 345 
named M1-1 to M1-52 and they are encoded by 92.6% of the genome. Subsequent BLASTp 346 
searches identified homologues for 32 of the ORFs, from other “KMV-like” phages (Table S1). 347 
In most cases it was therefore possible to assign putative functions and  categorize ORFs as 348 
encoding either metabolism, structural or host lysis genes (Fig. 1A). ΦM1 also encodes a single 349 
tRNAIle, between phiM1-38 and phiM1-39. 350 
 351 
ΦM1 escape mutations had specific base substitutions 352 
The genome sequences of the three escape phages, M1-A, -B and -D, were compared with that of 353 
the wt. All three escape phages had single point mutations localized to a 124 bp stretch (Fig. 1B), 354 
across phiM1-22 and phiM1-23, which we refer to as the “escape locus”. To ascertain whether 355 
these point substitutions were individual changes, further escape phages were isolated using 356 
independent lysates to avoid the possibility of sibling mutants. The new escape phage mutants 357 
were isolated following selection on Pba pTA46 (ToxINPa) (22, 29). The escape locus of each 358 
phage was sequenced following amplification of the region from the purified genomic DNA. We 359 
observed that all 10 escape phages had unique mutations distributed across 246 bp of the escape 360 
locus (Fig. 1B). Nine of these mutations were base substitutions while one was a single base 361 
deletion (Table 4). 362 
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Infection with ΦM1 affects the ToxIPa:ToxNPa ratio 363 
Though it has been shown that ToxNPa levels do not alter during an ΦM1 phage infection (29), it 364 
was not known how the ToxIPa levels were affected. The identification of the escape phages 365 
provided an opportunity to address this question. To investigate alterations to the ToxIPa:ToxNPa 366 
ratio, we monitored the levels of ToxIPa and ToxNPa-FLAG during the infections by ΦM1 and 367 
the escape phage, ΦM1-O, within Pba carrying a ToxINPa-FLAG plasmid (pMJ4). Total protein 368 
and RNA samples were taken at different times after infection and subjected to Western Blot and 369 
S1-nuclease assay, respectively. While ToxNPa levels stayed constant throughout infection (Fig. 370 
2A, lower panel), ToxIPa levels dropped dramatically after 30 minutes compared to an uninfected 371 
control (Fig. 2A). Interestingly, ToxIPa levels increased back to original levels at 60 minutes. In 372 
comparison to the infection with ΦM1 wt, ToxIPa levels did not change significantly at 30 373 
minutes during infection with the escape phage ΦM1-O (Fig. 2B). The ToxIPa level did decrease 374 
with the ΦM1-O infection, but only at 40 minutes (Fig. 2B). The ToxIPa levels were not then 375 
restored, as in the case of ΦM1 wt (Fig. 2B). ΦM1 appears to activate ToxNPa, and thereby 376 
initiate Abi, by causing a decrease in the cellular ToxIPa levels, either through direct or indirect 377 
means. In the case of ΦM1-O, this activation is prevented due to the mutation in M1-23. This 378 
would allow the phage to propagate, which may then account for the delayed decrease and lack 379 
of restoration in ToxIPa levels. 380 
 381 
 382 
 383 
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Identification and characterization of the ΦM1 escape product 384 
The majority of escape mutations occurred within phiM1-23. On first analysis, two mutations, 385 
those from ΦM1-B and ΦM1-X, occurred at the 3ʹ end of phiM1-22. Another mutation, from 386 
ΦM1-C, mapped further upstream, again within phiM1-22. This gene, phiM1-22, encodes a 387 
homologue of a putative DNA exonuclease from phage LKA1 (Table S1) (44). Unfortunately, 388 
there were no database hits for phiM1-23 and phiM1-24, using either the nucleotide or encoded 389 
protein sequences. 390 
 Specific regions of this escape locus were amplified from ΦM1 phages, then cloned into 391 
pBAD30 (48) to make inducible constructs (Fig. 3A and 3B). The cloning began with constructs 392 
1-6, using DNA from ΦM1 wt and ΦM1-B (Fig. 3B). Constructs 1 and 2 could not be obtained 393 
with ΦM1 wt DNA presumably through toxicity of the resulting wt constructs in E. coli DH5α, 394 
though could be made using ΦM1-B escape phage DNA. Constructs 3, 4, 5 and 6 could be made 395 
using both sources of DNA. Due to the regions covered by these constructs we could determine 396 
that within this locus the genes of interest were phiM1-22 and phiM1-23, and that phiM1-24 did 397 
not contribute to toxicity. As pBAD30 is tightly repressed by glucose in E. coli DH5α, this also 398 
implied that toxicity from this region of DNA might be occurring via an internal promoter. 399 
 Upon first analysis, the putative ATG start of phiM1-23 was at 15,304 bp. Taking into 400 
account the STOP codons of each frame (green vertical lines, Fig. 1B), the putative ATG start 401 
codon of phiM1-23 could theoretically have been upstream of this initial annotation. There were 402 
three possible ATG sites upstream of the putative start codon for phiM1-23. The mutation of 403 
ΦM1-C specifically altered the middle of these start codons from M to T (Table 4). This start 404 
codon also had a ribosome binding site closer to consensus than those of the other potential start 405 
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codons, making it the most obvious candidate. If this were the case, the escape mutations would 406 
span phiM1-23 specifically. Constructs 7-9 were designed and made, in order to test whether 407 
phiM1-23 alone could generate a toxic phenotype. 408 
 We performed experiments to assess the toxicity of the escape locus constructs and to 409 
determine whether toxicity was related to the presence of ToxINPa. Pba was transformed with 410 
inducible derivatives of the escape locus in combination with either pBluescript-based 411 
(Fermentas) ToxINPa or negative control ToxINPa-frameshift (FS) vectors (pTRB125 and 412 
pTRB126, respectively). Serial dilutions of these dual-vector strains of Pba were then incubated 413 
with and without induction, overnight, to determine the viable count (Fig. 3C). This clearly 414 
showed that the product of construct 7, covering phiM1-23 specifically, was toxic. There was no 415 
toxicity in the case of ΦM1-B, the mutation in which causes a premature STOP codon in phiM1-416 
23. Toxicity was also independent of the presence of ToxINPa. These results strongly suggested 417 
that phiM1-23 produces a small, toxic protein, responsible either directly or indirectly, for 418 
activation of Abi against ΦM1. 419 
New versions of construct 7 (Fig. 3D) were then generated, adding a C-terminal FLAG 420 
tag to the M1-23 product, using both ΦM1 wt and escape sequences. Various constructs were 421 
then tested for toxicity in the cognate host, Pba (Fig. 3D). All the escape constructs tested 422 
showed reduced toxicity (Fig. 3D). It was therefore possible to attempt over-expression and 423 
purification of M1-23, using an E. coli expression strain, ER2566. After expression trials using 424 
constructs made from ΦM1 wt, -O, -W and -Y phage DNA, the M1-O-23FLAG product was 425 
chosen for further study. Sufficient M1-O-23FLAG protein was purified to allow mass 426 
spectrometry to confirm both the identity of the protein, and specifically the presence of the 427 
expected Q to P mutation. Furthermore, the protein sample was subjected to N-terminal 428 
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sequencing, generating a sequence of TKM. This implied that phiM1-23 started at the ATG 429 
specifically mutated by ΦM1-C, as described earlier, and that the initial methionine is cleaved 430 
post-translationally. The annotation of the ΦM1 wt genome was then altered to accommodate 431 
phiM1-23 beginning at this confirmed start codon. In summary, this result shows that all the 432 
escape mutations map to a single gene, phiM1-23, which generates a 9.8 kDa protein. These 433 
mutations reduce toxicity of the protein product, and allow viral escape from ToxINPa-induced 434 
Abi. 435 
It had not been possible to clone constructs 1 and 2 (Fig. 3B) using the ΦM1 wt 436 
sequence, despite the pBAD30 vector system being repressed in the presence of glucose. This 437 
suggested that a promoter internal to those cloned regions might be inducing transcription of 438 
phiM1-23. A range of pRW50-based (49), lacZ transcriptional fusion constructs was generated to 439 
investigate the possible presence of a promoter (Fig. S3A). In this case, it was possible to clone 440 
the equivalent of construct 2 using ΦM1 wt DNA (Fig. 3B), perhaps due to pRW50 having a low 441 
copy number, so the level of toxicity was sufficiently low. Plasmid pTA104 (22), containing the 442 
promoter for ToxINPa, was used as a positive control. All the test constructs except pTRB162, 443 
which was an extremely truncated clone, generated LacZ activity (Fig. S3B). This confirmed the 444 
presence of a weak phiM1-23 promoter within phiM1-22.  445 
 446 
Extensive analysis of ΦM1 escape mutants map all mutations to phiM1-23 447 
The initial 10 escape mutants of ΦM1 all had unique mutations in M1-23, so it was likely that 448 
there were other possible mutations not yet observed. Identifying these other mutations could 449 
reveal important residues involved in the functionality of M1-23. Consequently, a larger library 450 
of escape mutants was isolated and characterized in the same way as the initial escapes. A total 451 
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of 51 new, independent escape phages were isolated and their phiM1-23 sequences were 452 
characterized. All escapes were shown to have a mutation in this region and several new unique 453 
escapes were isolated (Table S2). With the addition of these new escapes the number of different 454 
mutations increased to 20. Interestingly, mutations in all three of the bases of the putative start 455 
codon were isolated, consistent with this being the correctly annotated start site. Other interesting 456 
mutations were those causing N-terminally located  truncations of M1-23. In particular, ΦM1-457 
E11 produced only a hypothetical dipeptide or indeed just a single amino acid if the intial 458 
starting methionine were removed. Although most mutations in M1-23 were missense alleles 459 
generating single amino acid residue changes, the ability to isolate derivatives with major 460 
truncations showed that the M1-23 protein must be non-essential for a productive ΦM1 lytic 461 
cycle. Other notable mutations were ΦM1-E48 and 49 (both generating the same outcome), 462 
which modify the stop codon and lead to a 10 amino acid C-terminal extension. It is puzzling 463 
why the 10-mer extension might impact function, because the addition of the octameric FLAG 464 
tag to the C-terminus of M1-23 did not disrupt protein toxicity. Perhaps the extension might 465 
harbour a sequence that could act as an auto-inhibitor or disrupt protein structure. 466 
 467 
M1-23 interacts with UvrA but abortive infection can still take place in UvrA-468 
deficient P. atrosepticum 469 
To assess whether there is a direct interaction of M1-23 with the ToxINPa complex, His-tagged 470 
forms of both M1-23 and M1-O-23 were cloned, allowing over-expression and purification of 471 
these proteins. Co-immunoprecipitation reactions were carried out but the results showed no 472 
evidence for interactions between M1-23 and the ToxINPa complex, and that M1-23 had no 473 
impact on the ToxI RNA (data not shown). 474 
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 During the process of purifying M1-23-6His it was noted that an additional high 475 
molecular weight band appeared in the eluted sample that was not present in control samples, 476 
which then co-purified with M1-23 following ion exchange FPLC (data not shown). Mass 477 
spectrometric analysis identified the host nucleotide excision repair protein, UvrA. Reciprocal 478 
co-immunoprecipitation assays were performed using purified protein samples to confirm this 479 
interaction (Fig. 4). M1-23 protein retained UvrA while M1-O-23 did not, and similarly, only 480 
M1-23 was retained by immobilized UvrA (Fig. 4). This strongly suggests that M1-23 is a viral 481 
product that is able to bind host UvrA. 482 
 To assess potential effects of UvrA in abortive infection, a uvrA mutant was constructed 483 
in P. atrosepticum, confirmed by sequencing and then by hypersensitivity to UV light (Fig. S1). 484 
This strain was tested for its ability to abort ΦM1 via the ToxINPa system. Surprisingly, ΦM1 485 
was still aborted in the uvrA mutant and to the same extent as in the wild type Pba strain (EOP of 486 
ΦM1 on uvrA mutant with ToxINPa is 1.1x10-5). Escapes of ΦM1 were isolated from the uvrA 487 
mutant and their DNA was sequenced. Interestingly, all escapes isolated on the uvrA mutant, 488 
ΦM1-U1, U2 and ΦM1-U4 to U10 (which were independently isolated), carried mutations in the 489 
M1-23 sequence (Table S2). The results suggest that although M1-23 clearly has a specific 490 
interaction with UvrA, it appears that the escape route is either subtle or occurs indirectly.  491 
 492 
The ΦM1 escape mechanism works in another Type III TA and Abi system 493 
Two further families of Type III TA systems were recently identified, CptIN and TenpIN (23). 494 
TenpINPl, from the chromosome of Photorhabdus luminescens TT01, was able to act as an Abi 495 
system against coliphages when cloned on a multicopy plasmid and tested in an E. coli 496 
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background (23). By transforming P. atrosepticum SCRI1043 with the TenpINPl expression 497 
plasmid, pFR2 (23), we were able to test three Pectobacterium phages against the Abi activity of 498 
TenpINPl (Table 5). While ΦS61 (29) and ΦTE (27) were dramatically affected by ToxINPa, 499 
neither were inhibited by TenpINPl (Table 5). This indicates a degree of selectivity between the 500 
two Abi systems. ΦM1, however, was aborted by both systems, though to different degrees, 501 
which also underlines the selectivity under which ToxINPa and TenpINPl appear to operate. As 502 
with ToxINPa, it was possible to select for phages of ΦM1 that escaped Abi by TenpINPl. One of 503 
these escape phages, ΦM1-PL2, was isolated and sequenced. This escape phage had a single 504 
base substitution, T15410C, the same mutation as ΦM1-D. To test this in reverse, escape phage 505 
ΦM1-O, selected with ToxINPa, was tested against TenpINPl (Table 5). ΦM1-O was also 506 
resistant to TenpINPl. These results imply that, in the case of ΦM1, both systems operate in a 507 
similar fashion with a single protein, M1-23, being a key mediator. 508 
 509 
 510 
 511 
 512 
 513 
 514 
 515 
 516 
 517 
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DISCUSSION 518 
The pectobacterial phage ΦM1 was shown previously to be sensitive to the ToxINPa system and 519 
capable of producing spontaneous escape mutants (29). Here we found that the ΦM1 phage is 520 
also sensitive to TenpINPl when reconstructed in P. atrosepticum and is correspondingly able to 521 
evolve escape mutants. This is the first time we have been able to identify a phage able to escape 522 
the TenpINPl system and so further study may provide information about its activation. 523 
Interestingly, the ΦM1 phage is insensitive to two other Type III systems tested, ToxINBt from 524 
Bacillus thuringiensis and the CptINEr system from Eubacterium rectale (data not shown) and no 525 
Abi activity has so far been observed in these two systems (23, 50). In contrast, the P. 526 
atrosepticum phage ΦTE is aborted by ToxINPa and able to escape the system by RNA-based 527 
molecular mimicry of the antitoxin (27) but is not aborted by the TenpINPl system (Table 5).  528 
Characterization of the ΦM1 phage in this study has shown that all escapes selected on 529 
ToxINPa or TenpINPl have mutations in a gene encoding M1-23. Alteration of single amino acids, 530 
extreme truncations due to very 5ʹ stop codons, or even stop codon mutations leading to short C-531 
terminal extensions of M1-23 cause insensitivity to both ToxINPa and TenpINPl. Escapes selected 532 
on one system are also insensitive to the other system, suggesting that there is a common 533 
pathway for the ΦM1 phage in the activation of these two systems. The role of M1-23 is 534 
unknown, but it was shown to be non-essential and as it is located between a predicted 535 
exonuclease phiM1-22 and a predicted endonuclease gene phiM1-25, it could have a role in the 536 
regulation of nucleases or indeed may be able to act as a nuclease itself. In a previous study it 537 
was shown that ToxNPa levels do not change during infection of the ΦM1 phage (29). In this 538 
study we found that the ToxIPa levels decrease 30 minutes post-infection. In contrast, during the 539 
infection by the ΦM1 escape phage, ΦM1-O, ToxIPa levels only slightly decreased after 40 540 
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minutes and were not restored. It appears that wild type ΦM1 activates ToxNPa by decreasing the 541 
levels of ToxIPa and therefore initiating Abi. For ΦM1-O, the mutation in M1-23 prevents this 542 
early activation and thereby provides a window of opportunity for the phage to replicate.  543 
To investigate the mechanism of M1-23 action, a large number of ΦM1 escape phages 544 
were isolated and their phiM1-23 regions were sequenced. The results showed a number of 545 
escape mutations near the 5ʹ end of the gene, resulting in extremely truncated versions of the 546 
protein. This confirms that M1-23 is a non-essential viral protein. However, the majority of 547 
mutations found were towards the 3ʹ region of the gene and were mostly missense mutations 548 
resulting in single amino acid changes, implying that the C-terminal domain of the protein is 549 
important for Abi functionality. To further characterize M1-23, it was overexpressed and purified 550 
but, due to high toxicity, only a small amount of protein could be produced. Using the limited 551 
amount of protein available, interaction studies were performed to see if M1-23 interacted with 552 
ToxINPa. During purification of M1-23, a high molecular weight protein always co-purified. 553 
Mass spectrometry of this protein confirmed that it was the DNA repair protein UvrA. It was 554 
shown through co-immunoprecipitation experiments that while M1-23 could interact with UvrA, 555 
the escape version of the protein M1-O-23 could not.  556 
UvrA forms part of the SOS response in bacteria - a DNA damage response pathway (51) 557 
that has previously been shown to be involved in TA activation. The Type I TA system TisB-558 
IstR is under direct SOS response control, as tisAB which encodes the TisB toxin contains a 559 
LexA operator region that is inhibited by LexA (52). As well as the SOS response, the stringent 560 
response has also been shown to play a role in the activation of TA systems. Both Type I and 561 
Type II TA systems have been shown to be regulated by (p)ppGpp, the central regulator of the 562 
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stringent response (53, 54). However, ΦM1 and ΦTE were tested in a (p)ppGpp negative double 563 
mutant (relA, spoT) and were still aborted in that background (data not shown). 564 
During the course of this study, two new pectobacterial phage genomes were sequenced. 565 
These were P. atrosepticum phage Peat1 (55), (GenBank accession KR604693) and P. 566 
carotovorum phage PPWS1 (56), (DDBJ accession number LC063634). Both of these were 567 
podoviruses that shared high sequence identity to ΦM1. Peat1 (45,6533 bp) shared 77.7% 568 
sequence identity and PPWS1 (44,539 bp) shared 59.7% sequence identity. Furthermore, 569 
analysis of both genomes revealed that both phages encoded M1-23 homologs with the Peat1 570 
homolog only differing by a single amino acid. Therefore, it is highly likely that both phages 571 
would be aborted by both the ToxINPa and TenpINPl systems and evolve escapes in the same 572 
way. If this was the case, it would show a common route through which phages of different 573 
bacteria are able to escape the same system. 574 
Both ToxINPa and TenpINPl are very powerful anti-phage abortive infection systems that 575 
belong to two different families of Type III TA systems and are effective against a wide variety 576 
of phages. While many phages show differing sensitivity to the two systems, this study has 577 
shown that in ΦM1 there is a common pathway through which these two families of Type III TA 578 
systems can be activated. This pathway involves a small toxic protein, M1-23, of unknown 579 
metabolic function that does not directly interact with the ToxINPa complex, but interacts directly 580 
with UvrA. ΦM1 infection causes a diminution in ToxIPa levels presumably leading to the 581 
destabilization of the ToxINPa complex and consequent liberation of ToxNPa to induce cell death 582 
and concomitant abortive infection of the viral parasite.  583 
 584 
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Figure legends 742 
 743 
FIG 1 Genomic map of ΦM1 wild type and its escape locus. (A) All the fifty-two annotated 744 
ORFs are coded on the forward reading strand, in a linear progression from metabolic genes, to 745 
structural genes and finally host cell lysis genes. Each forward reading frame is labelled; F1, F2 746 
or F3. ORFs are shown to scale as shaded boxes numbered with the gene number, coloured 747 
according to predicted role. The single tRNAIle gene is positioned on the scale, shown in purple. 748 
Where it has been possible to identify a protein by homology searches, that ORF is labelled. The 749 
scale is in base-pairs. The figure was drawn to scale using Adobe Illustrator. (B) Schematic of 750 
the escape locus of ΦM1. All escape phage mutations are within phiM1-23. Each forward 751 
reading frame is labelled; F1, F2 or F3. Each ORF is shown to scale as a box, numbered with the 752 
gene number. Each STOP codon is represented as a green vertical line. The positions of the ΦM1 753 
escape phage mutations are shown by red vertical lines, labelled with the parent phage. The scale 754 
is in base pairs.  755 
 756 
FIG 2 ToxIPa levels are affected during phage infection. (A) S1-nuclease assay targeting the full 757 
5.5 repeat ToxIPa sequence was used to monitor ToxIPa levels during ΦM1 infection. Assays 758 
were performed on 10 µg total RNA prepared from Pba ToxINPa (pMJ4) at different times 759 
following ΦM1 infection. Numbers indicate the time (min) after infection with phage (+ ΦM1) 760 
and the negative control without phage (- ΦM1). Hybridization to total RNA from Pba 761 
expressing ToxINPa (pTA46) and DH5α served as positive and negative controls, respectively. 762 
The expression of ToxNPa at the respective time points of infection is shown in the lower panel 763 
using Western Blot; C indicates the 11 kDa SdhE-FLAG protein used as a loading and size 764 
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control (41). (B) S1-nuclease assay targeting ToxIPa for the infection with the escape phage 765 
ΦM1-O. The assay was done as in (A). 766 
 767 
FIG 3 Toxicity of the ΦM1 escape locus products. (A) The escape locus of ΦM1 as per Fig. 1B. 768 
The positions of the ΦM1 escape phage mutations are shown by red vertical lines, labelled with 769 
the parent phage. The scale is in base pairs. (B) Specific regions of the phage genomes, 770 
designated by the length of the line that corresponds to the genomic locus shown in (A), were 771 
cloned into pBAD30 to make nine different constructs. Blue dotted lines in (A) reflect the 772 
construct boundaries in (B). The figure is drawn to scale. (C) Expression of ΦM1 wt and ΦM1-B 773 
escape loci in Pba. Strains of Pba containing either a ToxINPa or ToxINPa-FS plasmid (pTRB125 774 
or pTRB126), together with a phage construct (or pBAD30 vector control) were tested for 775 
toxicity. (D) A range of construct 7 plasmids was tested for toxicity in Pba. The escape phage 776 
constructs were all reduced for toxicity. Error bars show the standard deviation in triplicate data. 777 
 778 
FIG 4 Co-immunoprecipitation of M1-23, M1-O-23 and UvrA. (A), and (B) show co-779 
immunoprecipitation experiments with wild type M1-23 and UvrA. In (A) M1-23-6His was used 780 
as the bait and attached to a Ni+ column with UvrA-FLAG passed through. In (B) the reciprocal 781 
experiment was performed with UvrA-6His used as the bait and M1-23-FLAG was passed 782 
through. (C), and (D) show the same co-immunoprecipitation experiments using M1-O-23 783 
instead of M1-23. In (C) M1-O-23 was used as the bait and in (D) UvrA-6His was used as bait. 784 
  785 
 o
n
 February 9, 2017 by UNIV O
F DURHAM
http://aem
.asm
.org/
D
ow
nloaded from
 
 38
Tables 786 
TABLE 1 Bacterial strains and bacteriophages used in this study 
Bacteria Genotype/ Characteristics Source 
E. coli β2163 F- RP4-2-Tc::Mu dapA ::(erm-pir), KmR (57) 
E. coli DH5α F- endA1 glnV44 thi-
1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ– 
Gibco/BRL 
E. coli ER2566 F- λ- fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 
Δ(mcrC-mrr)114::IS10 R(mcr-73::miniTn10-TetS)2 
R(zgb-210::Tn10)(TetS) endA1 [dcm] 
NEB 
E. coli W3100 F- λ- rph-1 INV(rrhD, rrhE) (58) 
Pectobacterium 
atrosepticum 
SCRI1043 
Wild type strain (31) 
   
Phages Characteristics Source 
ΦM1 Podoviridae, propagated on wt SCRI1043 (30) 
ΦM1-A ToxINPa-escape mutant of ΦM1 (29) 
ΦM1-B ToxINPa-escape mutant of ΦM1 (29) 
ΦM1-C ToxINPa-escape mutant of ΦM1 (29) 
ΦM1-D ToxINPa-escape mutant of ΦM1 (29) 
ΦM1-O ToxINPa-escape mutant of ΦM1 This study 
ΦM1-V ToxINPa-escape mutant of ΦM1 This study 
ΦM1-W ToxINPa-escape mutant of ΦM1 This study 
ΦM1-X ToxINPa-escape mutant of ΦM1 This study 
ΦM1-Y ToxINPa-escape mutant of ΦM1 This study 
ΦM1-Z ToxINPa-escape mutant of ΦM1 This study 
ΦM1-Q ToxINPa-escape mutant of ΦM1 This study 
ΦM1-E1 to E49 ToxINPa-escape mutant of ΦM1 This study 
ΦM1-U1 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U2 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U4 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U5 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U6 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U7 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U8 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U9 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-U10 ToxINPa-escape mutant of ΦM1 on UvrA mutant This study 
ΦM1-PL2 TenpINPl-escape mutant of ΦM1 This study 
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TABLE 2 Primers used in this study 
Primer Sequence (5ʹ-3ʹ) Description Restriction site 
KDOI TTTTGGATCCGTTTTATCGACATTGTGAACC toxIN locus BamHI 
PF147 GTATCTAGAGTAGTCGCCTCTTTTACTTTATTA
C 
toxI XbaI 
PF217 TTGTATACTTAAGTTATTGACTCTATAGCTCAG ToxI amplification 
for S1-nuclease 
protection assay 
HindIII 
PF218 TTGACTATGTAGTCGCCTCTTTTACTTTATTTC
GAACCTCGGACCTGCG 
 
  
ToxI amplification 
for S1-nuclease 
protection assay DrdI 
TRB37  CCGGCATATGAAATTCTACACTATATCAAGC 
 
Used for ToxIN 
CBD NdeI 
TRB38  GTGGTTGCTCTTCCGCACTCGCCTTCTTCCGTAT 
 
Used for ToxIN 
CBD SapI 
TRB107 TTGAATTCTGCGCAAGCAACTGGTGCACC ΦM1 sequencing 
primer EcoRI 
TRB108 TTAAGCTTCTTGAATCTGTACTCACCG ΦM1 sequencing 
primer 
 
HindIII 
TRB111  TTGAATTCCTGTAGGAGCGTGGAATGC 
 
ΦM1 escape locus EcoRI 
TRB115 TTGAATTCCAGGGGTGTTACCTACTCC ΦM1 sequencing 
primer EcoRI 
TRB116  TTAAGCTTGTAACTGTGCAGTGATACC 
 
ΦM1 sequencing 
primer HindIII 
TRB117 TTGAATTCCCTACAATGCCCCAGATGC ΦM1 escape locus  
EcoRI 
TRB118 TTAAGCTTACGGTCGTACTTGGCTTCG ΦM1 escape locus  HindIII 
TRB125 TTAAGCTTCTAATCCTACGCCTTGTGC ΦM1 escape locus HindIII 
TRB126 TTGAATTCAAGGTGGATGCAACTCGGG ΦM1 escape locus EcoRI 
TRB127 TTAAGCTTCTCTACATCATCCAACATC ΦM1 escape locus HindIII 
TRB128 TTGAATTCGAGCTGCGTGATGAGTTCC ΦM1 escape locus EcoRI 
TRB129 TTGAATTCGCTTACCCGATTATATCC ΦM1 escape locus EcoRI 
TRB130 TTGAATTCCCAATTTAAAATTAATGA ΦM1 escape locus EcoRI 
TRB134 TTAAGCTTATTACTTGTCATCGTCGTCCTTGTA
GTCTCCTAGGTACCCCATCTGG 
ΦM1 construct 
7/ORF23 FLAG HindIII 
TRB135  TTAAGCTTAGTGATGGTGATGGTGATGTCCTCC TAGGTACCCCATCTGG 
 
ΦM1 construct 
7/ORF23-6His HindIII 
TRB332  TTAAGCTTATTACTTGTCATCGTCGTCCTTGTA GTCTCCCAGCATCGGCTTAAGGAAGCG 
 
uvrA-FLAG HindIII 
TRB337 ATTAGGATCCGATAAGATCGAAGTTCG uvrA primer BamHI 
TRB338 ATTAAAGCTTTTACAGCATCGGCTTAAG uvrA primer HindIII 
UvrA dnF TTTATTCCGGGAAGTGTGTGAATTTAAATTAG
CGAGAGGCCAAATCATG 
Fwd, 500bp 
downstream of 
uvrA 
SwaI 
UvrA dnR TTATCAGAATTCCTGCCGTGCAGGCAGTTCAG Rev, 500bp 
downstream of 
uvrA 
EcoRI 
UvrA upF TTATCATCTAGATTGCAGTGCGCCTTCGATG Fwd, 500bp 
upstream of uvrA XbaI 
UvrA upR CATGATTTGGCCTCTCGCTAATTTAAATTCACA
CACTTCCCGGAATAAA 
Rev, 500bp 
upstream of uvrA SwaI 
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TABLE 3 Plasmids used in this study 
Name Description Construction Template Resistance 
pACYC184 Cloning vector (59) - Cm 
pBR322 E. coli cloning vector NEB - Ap, Tc 
pFR2 Photorhabdus luminescens TT01 full TenpINPl locus 
(23) 
  pBR322 Ap 
pKNG-uvrA UvrA marker exchange construct 
UvrA upF, UvrA 
upR, UvrA dnF, 
UvrA dnR 
pKNG101 Tc, Kan 
pKNG101-TcR Marker exchange suicide vector (60) - Tc 
pMAT7 SdhE-FLAG expression vector (41) pBAD30 Ap 
pMJ4 toxIPa, ToxNPa-FLAG with native promoter in pBR322 (29) pBR322 Ap 
pQE80L Protein expression vector Qiagen - Ap 
pRW50 Promoterless LacZ (49) - Tc 
pTA46 ToxINPa with native promoter (29) pBR322 Ap 
pTA104 ToxINPa promoter (22) pRW50 Tc 
pTA110 In vitro transcription vector for antisense ToxIPa RNA PF217, PF218 pBSII SK
- Ap 
pTRB18-KP14 ToxIPa containing KDO1, PF147 pACYC184 Cm, Tt 
pTRB14 ToxNPa CBD TRB37, TRB38 pTA46 Ap 
pTRB113 ΦM1 wt construct 3 TRB126+TRB118 pBAD30 Ap, glu 
pTRB114 ΦM1 wt construct 4 TRB117, TRB127 pBAD30 Ap, glu 
pTRB115 ΦM1 wt construct 5 TRB126, TRB125 pBAD30 Ap, glu 
pTRB116 ΦM1 wt construct 6 TRB128, TRB118 pBAD30 Ap, glu 
pTRB121 ΦM1-B construct 2 TRB117, TRB125 pBAD30 Ap, glu 
pTRB123 ΦM1-B construct 4 TRB117, TRB127 pBAD30 Ap, glu 
pTRB124 ΦM1-B construct 5 TRB126, TRB125 pBAD30 Ap, glu` 
pTRB133 ΦM1 wt construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB134 ΦM1 wt construct 8 TRB129, TRB125 pBAD30 Ap, glu 
pTRB135 ΦM1 wt construct 9 TRB130, TRB125 pBAD30 Ap, glu 
pTRB136 ΦM1-A construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB139 ΦM1-B construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB140 ΦM1-B construct 8 TRB129, TRB125 pBAD30 Ap, glu 
pTRB141 ΦM1-B construct 9 TRB130, TRB125 pBAD30 Ap, glu 
pTRB148 ΦM1 wt construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu 
pTRB151 ΦM1-O construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu 
pTRB153 ΦM1-W construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu 
pTRB154 ΦM1-Y construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu 
pTRB155 ΦM1-D construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB156 ΦM1-O construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB157 ΦM1-V construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB158 ΦM1-W construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB159 ΦM1-Y construct 7 TRB111, TRB125 pBAD30 Ap, glu 
pTRB160 ΦM1 wt LacZ fusion construct TRB117, TRB127 pRW50 Tc 
pTRB161 ΦM1 wt LacZ fusion construct TRB111, TRB127 pRW50 Tc 
pTRB162 ΦM1 wt LacZ fusion construct TRB126, TRB127 pRW50 Tc 
pTRB163 ΦM1-O LacZ fusion construct TRB117, TRB125 pRW50 Tc 
pTRB164 ΦM1 wt LacZ fusion construct TRB117, TRB125 pRW50 Tc 
pTRB189 ΦM1-23-6His TRB111, TRB135 pQE-80L Ap 
pTRB190 ΦM1-O-23-6His TRB111, TRB135 pQE-80L Ap 
pTRB300 UvrA-FLAG TRB330, TRB332 pBAD33 Cm, glu 
pTRB301 UvrA-6His TRB337, TRB338 pQE-80L Ap 
  789 
 o
n
 February 9, 2017 by UNIV O
F DURHAM
http://aem
.asm
.org/
D
ow
nloaded from
 
 41
TABLE 4 Summary of ΦM1 escape mutations and effects on reading frames 
Phage Date of isolation 
Mutation 
relative to 
ΦM1 wt 
Effect on forward reading framesa 
F1 F2 F3 
      
ΦM1-A Mar 2007 15416 A to C Y to S T to P No change 
ΦM1-B Mar 2007 15292 C to T R to STOP No change P to L 
ΦM1-C Mar 2007 15170 T to C M to T STOP to S No change 
ΦM1-D Mar 2007 15410 T to C M to T W to R No change 
ΦM1-O Jun 2009 15407 A to C Q to P No change No change 
ΦM1-V May 2009 15415 T to G Y to D No change V to G 
ΦM1-W May 2009 15398 A to T D to V M to L STOP to C 
ΦM1-X May 2009 15288 AA to A FS to STOP after 
9 aa (wild type 
F1 continues 
phiM1-23) 
FS causing Q 
to H and STOP 
after 3 aa (wild 
type F2 stops 
after 9 aa) 
FS causing N to T 
and shift of ORF1 
into ORF2 (wild 
type F3 stops 
after 3 aa) 
   
   
   
ΦM1-Y May 2009 15397 G to A D to N No change No change 
ΦM1-Z May 2009 15416 A to G    
(cf M1-A) 
Y to C T to A No change 
 
a 'FS', frameshift; 'aa', amino acid 
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TABLE 5 EOPs against ToxINPa and TenpINPl Type III TA systems 
Phage EOP vs ToxINPa EOP vs TenpINPl Escape selected on 
    
ΦM1 wt 1.3 x 10-5 1.1 x 10-2  - 
ΦS61 <3.2 x 10-9 0.9  - 
ΦTE 1.0 x 10-8 0.7  - 
ΦM1-O 1.0 1.0 ToxINPa 
ΦM1-PL2 0.9 0.9 TenpINPl 
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